Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2026-04-08 @ 10:59 AM
Study NCT ID:
NCT00279435
Status:
TERMINATED
Last Update Posted:
2012-03-12
First Post:
2006-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study
Sponsor:
Facet Biotech
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
291-417
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |